Outcome Measures
depression, depressive symptoms
ADVERSE EFFECTS
The primary outcome was time (in days) to therapeutic TCA plasma concentrations. Secondary outcomes were severity of depressive symptoms and frequency and severity of adverse effects. Severity of depressive symptoms was measured weekly through the HAMD-17 (score range, 0-52, with higher scores indicating greater depression severity)